Henry Schein had its Relative Strength (RS) Rating upgraded from 74 to 81 Tuesday.
IBD's proprietary rating tracks market leadership with a 1 (worst) to 99 (best) score. The score shows how a stock's price movement over the last 52 weeks holds up against all the other stocks in our database.
Decades of market research shows that the best stocks often have an RS Rating north of 80 in the early stages of their moves.
Looking For The Best Stocks To Buy And Watch? Start Here
While the stock is not near an ideal buying range right now, see if it manages to form and break out of a proper consolidation.
Henry Schein saw both earnings and sales growth rise last quarter. Earnings-per-share increased from -8% to 80%. Revenue rose from 0% to 6%.
Henry Schein earns the No. 1 rank among its peers in the Medical-Supplies industry group. Patterson Cos and Becton Dickinson are also among the group's highest-rated stocks.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Stocks With Rising Relative Strength Ratings
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
